Primary Biliary Cholangitis PBMC

In Stock Samples

Lot # Condition Cell Count (M) Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
73455 Primary Biliary Cholangitis (Cirrhosis) 10M Hispanic/Latino 44 Female
Ursodiol/500mg/TID Omeprazole/20mg/QD Zyrtec/10mg/QD Albuterol/PRN
2
73540 Primary Biliary Cholangitis (Cirrhosis) 10M Caucasian 56 Female
Ursodiol 1250mg total Ocaliva 10mg po qd Atorvastatin 40mg po qd Levothyroxine 150mcg po qd Pantoprozole 40mg po qd Rifampin 150mg po bid Calcium citrate 1200mg po qd
2
73724 Primary Biliary Cholangitis (Cirrhosis) 10M Caucasian 74 Male United States (US)
Crestor 10mg po qd Lipitor 10mg po qd Metformin 500mg po bid Vit D 500IU po qd Ursodiol 500mg AM --> 250mg lunch -->500mg PM QD Ozempic injectable qweekly medical marijuana vaping out of cartridge
8
73690 Primary Biliary Cholangitis (Cirrhosis) 10M Caucasian 75 Female United States (US)
Ursodiol 250 mg TID NOT on Ocaliva Topical ointment-Triamcinolone Acetonide 0.1% applied daily-pea sized amount.
3
73420 Primary Biliary Cholangitis (Cirrhosis) 10M Caucasian 63 Female United States (US)
lisinopril 10 mg QD cytamil for throid 5 mcg BID np (armoer thyroid) 60 mg QD omeprazole 40 mg QD baby aspirin ursodiol 250 mg x2 BID
2
55916 Primary Biliary Cholangitis (Cirrhosis) 5M Caucasian 74 Male United States (US)
Crestor 10mg po qd Lipitor 10mg po qd Metformin 500mg po bid Vit D 500IU po qd Ursodiol 500mg AM --> 250mg lunch -->500mg PM QD Ozempic injectable qweekly
6 $891.00
55896 Primary Biliary Cholangitis (Cirrhosis) 5M Caucasian Hispanic/Latino 44 Female United States (US)
Ursodiol 600mg BID Carosate 1mg 4/day lemotrogen 200mg QD Wellbutrin 100mg BID prylosec 20mg QD Adidrax 25mg every 6 hours Bentyl 20mg QD
6 $891.00

Primary Biliary Cholangitis PBMC for Research

Primary Biliary Cholangitis Human PBMC products are sourced from donors clinically diagnosed with Primary Biliary Cholangitis (PBC) and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies related to autoimmune liver damage including T cell response, B cell activity, and cytokine production.

Product Features

  • Research Use Only (RUO), cryopreserved PBMCs
  • Clinically confirmed PBC donors
  • Available in cell counts ranging from 5 million to 2 billion
  • Processed within 24 hours of collection
  • Stored using CryoStor® CS10 freezing media
  • IRB-approved protocols and electronic informed consent
  • Screen LeukoLot™ available prior to bulk orders

De-identified Donor Data

  • Verified PBC diagnosis
  • Donor demographics: age, sex assigned at birth, race/ethnicity
  • Self-reported allergies and infectious disease history
  • Additional PBC-specific data available upon request

Applications

  • Biomarker discovery and validation
  • Drug screening and therapeutic development
  • Immune pathway analysis in Primary Biliary Cholangitis (PBC) pathophysiology
  • Transcriptomic and proteomic profiling

Quality and Compliance

  • IRB-approved collections and protocols
  • 21 CFR Part 11 – compliant e-consent system
  • HIPAA-compliant donor data protection

Ordering & Shipping

Primary Biliary Cholangitis PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Frequently Asked Questions

Showing 13–24 of 30 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.

Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory

YES – Matched samples across multiple matrices are available, including synovial fluid are available.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information